Cevian Cuts UBS Stake by Over a Quarter as Capital Regulation Dispute Continues
nashnova research
Swedish activist investor Cevian Capital sold 26% of its UBS holding — roughly 12.6 million shares — in Q3, just as Switzerland pushes a regulatory overhaul that could force UBS to raise about $16 billion in extra capital.
How much did Cevian sell, and what's left?
Cevian offloaded about 12.6 million UBS shares in the third quarter ending September, cutting its position by 26%.
Its remaining stake sits at roughly 1%, still inside UBS's top-twenty shareholder list.
Cevian called it "minor portfolio rebalancing" — it needs capital for new investments, and UBS remains one of its largest holdings.
Why sell right now?
The backdrop: after Credit Suisse collapsed in 2023, Swiss regulators launched a review of capital rules for systemically important banks.
The leading proposal would require UBS to put up roughly $16 billion in additional capital. This means → distributable profits and buyback capacity would shrink sharply if the rule takes effect.
Cevian frames the sale as routine rebalancing. But the timing — peak regulatory uncertainty — makes that framing hard for the market to take at face value.
How is UBS management fighting the rule?
CEO Sergio Ermotti has warned that if the strict version passes, UBS would have to consider relocating its headquarters. In plain terms = that is a threat to leave Switzerland unless the government softens the rules.
Bloomberg reports UBS has not given up lobbying lawmakers; the lower house of parliament could vote as early as next month.
A Reuters report suggesting UBS may accept a regulatory "defeat" sent the stock down as much as 2.75% that day. This reflects how sensitive the market is to any signal that the strict version will stick.
What does Cevian itself think UBS should do?
Cevian has publicly stated that if the harsh version of the rules becomes law, UBS should leave Switzerland.
Since Cevian first disclosed its position, UBS shares have risen more than 50%. This means → even after trimming 26%, the trade has been highly profitable.
The key question ahead: will the extra capital requirement land, will it be watered down, or will UBS actually relocate? The answer will reshape the bank's valuation case.
市场有风险,内容仅供研究参考,不构成投资建议。
